{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T06:13:01Z","timestamp":1772431981385,"version":"3.50.1"},"reference-count":52,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[1994,1,1]],"date-time":"1994-01-01T00:00:00Z","timestamp":757382400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[1994,1]]},"DOI":"10.1016\/0959-8049(94)00286-e","type":"journal-article","created":{"date-parts":[[2004,4,17]],"date-time":"2004-04-17T23:13:19Z","timestamp":1082243599000},"page":"1424-1431","source":"Crossref","is-referenced-by-count":16,"title":["A randomised trial of MACC chemotherapy with or without lonidamine in advanced non-small cell lung cancer"],"prefix":"10.1016","volume":"30","author":[{"given":"G.","family":"Buccheri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Ferrigno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/0959-8049(94)00286-E_BIB1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0140-6736(93)91882-M","article-title":"Polychemotherapy in advanced non small cell lung cancer: a meta-analysis","volume":"342","author":"Souquet","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/0959-8049(94)00286-E_BIB2","series-title":"Recent Progress in Andrology","first-page":"453","article-title":"Antispermatogenic activity of diclondazolic acid in rats","author":"Silvestrini","year":"1978"},{"key":"10.1016\/0959-8049(94)00286-E_BIB3","first-page":"4661","article-title":"Effect of lonidamine on the energy metabolism of Ehrlich ascites tumor cells","volume":"41","author":"Floridi","year":"1981","journal-title":"Cancer Res"},{"key":"10.1016\/0959-8049(94)00286-E_BIB4","first-page":"497","article-title":"Lonidamine, a selective inhibitory of aerobic glicolysis of murine tumor cells","volume":"66","author":"Floridi","year":"1981","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/0959-8049(94)00286-E_BIB5","first-page":"273","article-title":"Kinetics of inhibition of mitochondrial respiration by antineoplastic agent lonidamine","volume":"5","author":"Floridi","year":"1986","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/0959-8049(94)00286-E_BIB6","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0014-4800(87)90027-X","article-title":"Cell membrane changes induced by lonidamine in human erythrocytes and T lymphocytes, and Ehrlich ascites tumor cells","volume":"46","author":"De Martino","year":"1987","journal-title":"Exp Molec Pathol"},{"key":"10.1016\/0959-8049(94)00286-E_BIB7","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/bjc.1983.30","article-title":"Effects of lonidamine alone or combined with hyperthermia in some experimental cell and tumor systems","volume":"47","author":"Silvestrini","year":"1983","journal-title":"Br J Cancer"},{"key":"10.1016\/0959-8049(94)00286-E_BIB8","first-page":"1120","article-title":"Potentiation of radiation effects on two murine tumors by lonidamine","volume":"46","author":"Kim","year":"1986","journal-title":"Cancer Res"},{"key":"10.1016\/0959-8049(94)00286-E_BIB9","first-page":"1245","article-title":"In vitro and in vivo potentiation by lonidamine of the antitumor effect of adriamycin","volume":"6","author":"Zupi","year":"1986","journal-title":"Anticancer Res"},{"key":"10.1016\/0959-8049(94)00286-E_BIB10","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/BF00694335","article-title":"Effects of lonidamine on the cytotoxycity of four alkylating agents in vitro","volume":"25","author":"Rosbe","year":"1989","journal-title":"Cancer Chemoth Pharmacol"},{"key":"10.1016\/0959-8049(94)00286-E_BIB11","first-page":"780","article-title":"Lonidamine as a modulator of alkylating agent activity in vitro and in vivo","volume":"51","author":"Teicher","year":"1991","journal-title":"Cancer Res"},{"key":"10.1016\/0959-8049(94)00286-E_BIB12","first-page":"195","article-title":"New perspectives in anticancer therapy: a review on lonidamine","volume":"25","author":"Putzolu","year":"1989","journal-title":"Drugs of Today"},{"issue":"suppl 4","key":"10.1016\/0959-8049(94)00286-E_BIB13","first-page":"42","article-title":"Phase III trial with and without lonidamine in non-small cell lung cancer","volume":"18","author":"Gatzemeier","year":"1991","journal-title":"Semin Oncol"},{"key":"10.1016\/0959-8049(94)00286-E_BIB14","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1177\/030089168907500112","article-title":"Lonidamine versus polychemotherapy in advanced nonsmall cell lung cancer. A preliminary analysis","volume":"75","author":"Giaccone","year":"1989","journal-title":"Tumori"},{"key":"10.1016\/0959-8049(94)00286-E_BIB15","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/bjc.1990.60","article-title":"Phase II study of lonidamine in non-small cell lung cancer: final report","volume":"61","author":"Kokron","year":"1990","journal-title":"Br J Cancer"},{"key":"10.1016\/0959-8049(94)00286-E_BIB16","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1159\/000238637","article-title":"Chronic administration of lonidamine in untreated non-small cell lung cancer of stage IIIMO-1","volume":"35","author":"Scagliotti","year":"1989","journal-title":"Chemotherapy"},{"key":"10.1016\/0959-8049(94)00286-E_BIB17","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1080\/1120009X.1990.11739053","article-title":"A phase II study on Lonidamine combined with cisplatin and etoposide in the treatment of advanced non-small cell bronchogenic carcinoma (NSCBC)","volume":"2","author":"Lelli","year":"1990","journal-title":"J Chemoth"},{"issue":"suppl 1","key":"10.1016\/0959-8049(94)00286-E_BIB18","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1159\/000225884","article-title":"A long-term clinical experience with lonidamine","volume":"41","author":"Battelli","year":"1984","journal-title":"Oncology"},{"issue":"suppl 7","key":"10.1016\/0959-8049(94)00286-E_BIB19","first-page":"26","article-title":"Chemotherapy\/radiation therapy plus\/minus lonidamine in the treatment of non-small cell lung cancer (limited disease): preliminary results","volume":"15","author":"Gallo-Curcio","year":"1988","journal-title":"Semin Oncol"},{"key":"10.1016\/0959-8049(94)00286-E_BIB20","first-page":"979","article-title":"Commentary: current status of chemotherapy for non-small cell lung cancer","volume":"65","author":"Aisner","year":"1981","journal-title":"Cancer Treat Rep"},{"key":"10.1016\/0959-8049(94)00286-E_BIB21","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1159\/000226718","article-title":"Combination of chemotherapy with methrotexate, adriamycin, cyclophosphamide, and CCNU (MACC) for non-small cell lung cancer: 4-year experience with 92 patients","volume":"46","author":"Buccheri","year":"1989","journal-title":"Oncology"},{"key":"10.1016\/0959-8049(94)00286-E_BIB22","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/1097-0142(19890201)63:3<428::AID-CNCR2820630305>3.0.CO;2-V","article-title":"Continuation of chemotherapy versus supportive care alone in patients with inoperable non-small cell lung cancer after two or three cycles of MACC","volume":"63","author":"Buccheri","year":"1989","journal-title":"Cancer"},{"key":"10.1016\/0959-8049(94)00286-E_BIB23","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0169-5002(90)90112-Y","article-title":"Further evidence in favour of chemotherapy for inoperable non-small cell lung cancer","volume":"6","author":"Buccheri","year":"1990","journal-title":"Lung Cancer"},{"key":"10.1016\/0959-8049(94)00286-E_BIB24","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1002\/1097-0142(19930901)72:5<1564::AID-CNCR2820720513>3.0.CO;2-A","article-title":"A phase II study of MACC chemotherapy and Lonidamine in advanced non-small cell lung cancer","volume":"72","author":"Buccheri","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/0959-8049(94)00286-E_BIB25","author":"World Health Organization","year":"1991"},{"key":"10.1016\/0959-8049(94)00286-E_BIB26","series-title":"Evaluation of Chemotherapeutic Agents","first-page":"199","article-title":"The clinical evaluation of chemotherapeutic agents in cancer","author":"Karnofsky","year":"1949"},{"key":"10.1016\/0959-8049(94)00286-E_BIB27","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1001\/jama.1977.03270490032019","article-title":"Chemotherapy for bronchogenic carcinoma: methotrexate, doxorubicin, cyclophosphamide, and lomustine","volume":"237","author":"Chahinian","year":"1977","journal-title":"JAMA"},{"key":"10.1016\/0959-8049(94)00286-E_BIB28","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1002\/1097-0142(197905)43:5<1590::AID-CNCR2820430504>3.0.CO;2-O","article-title":"MACC (methotrexate, adriamycin, cyclophosphamide, and CCNU) in advanced lung cancer","volume":"43","author":"Chahinian","year":"1979","journal-title":"Cancer"},{"key":"10.1016\/0959-8049(94)00286-E_BIB29","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6","article-title":"Reporting results of cancer treatment","volume":"47","author":"Miller","year":"1981","journal-title":"Cancer"},{"key":"10.1016\/0959-8049(94)00286-E_BIB30","first-page":"537","article-title":"Aspects of quality of life in patients with lung cancer: a three observer evaluation study","volume":"2","author":"Buccheri","year":"1993","journal-title":"Int J Oncol"},{"key":"10.1016\/0959-8049(94)00286-E_BIB31","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1200\/JCO.1991.9.11.2042","article-title":"The calculation of actual or received dose intensity: a comparison of published methods","volume":"9","author":"Longo","year":"1991","journal-title":"J Clin Oncol"},{"key":"10.1016\/0959-8049(94)00286-E_BIB32","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/sim.4780010204","article-title":"Tables of the number of patients required in clinical trials using the logrank test","volume":"1","author":"Freedman","year":"1982","journal-title":"Statist Med"},{"key":"10.1016\/0959-8049(94)00286-E_BIB33","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Non-parametric estimation from incomplete observations","volume":"58","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/0959-8049(94)00286-E_BIB34","first-page":"576","author":"Dixon","year":"1988"},{"key":"10.1016\/0959-8049(94)00286-E_BIB35","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life tables","volume":"34","author":"Cox","year":"1972","journal-title":"JR Stat Soc"},{"key":"10.1016\/0959-8049(94)00286-E_BIB36","author":"Siegel","year":"1956"},{"key":"10.1016\/0959-8049(94)00286-E_BIB37","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0021-9681(60)90137-5","article-title":"Appraisal of methods for the study of chemotherapy in man: comparative therapeutic trial of nitrogen mustard and triethylene thiophosphoramide","volume":"11","author":"Zubrod","year":"1960","journal-title":"J Chron Dis"},{"key":"10.1016\/0959-8049(94)00286-E_BIB38","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0169-5002(93)90306-I","article-title":"Carcinoembryonic antigen (CEA), tissue polyptide antigen (TPA), and other prognostic indicators in the squamous cell carcinoma of the lung","volume":"10","author":"Buccheri","year":"1993","journal-title":"Lung Cancer"},{"key":"10.1016\/0959-8049(94)00286-E_BIB39","article-title":"Serum tumour markers in lung cancer: history, biology and clinical applications","author":"Ferrigno","year":"1993","journal-title":"Eur Resp J"},{"key":"10.1016\/0959-8049(94)00286-E_BIB40","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1378\/chest.99.6.1325","article-title":"Chemotherapy and survival of patients with non-small cell lung cancer: a contrary view","volume":"99","author":"Haskell","year":"1991","journal-title":"Chest"},{"key":"10.1016\/0959-8049(94)00286-E_BIB41","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1378\/chest.99.6.1326","article-title":"Chemotherapy for non-small cell lung cancer: a continuing challenge","volume":"99","author":"Vokes","year":"1991","journal-title":"Chest"},{"key":"10.1016\/0959-8049(94)00286-E_BIB42","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1378\/chest.99.6.1328","article-title":"Chemotherapy and survival in non-small cell lung cancer. The old \u2018vexata questio\u2019","volume":"99","author":"Buccheri","year":"1991","journal-title":"Chest"},{"key":"10.1016\/0959-8049(94)00286-E_BIB43","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM199211123272006","article-title":"Drug therapy: chemotherapy of lung cancer","volume":"327","author":"Ihde","year":"1992","journal-title":"N Engl J Med"},{"issue":"suppl. 11","key":"10.1016\/0959-8049(94)00286-E_BIB44","first-page":"72","article-title":"The evolving role of systemic therapy in carcinoma of the lung","volume":"19","author":"Haraf","year":"1992","journal-title":"Semin Oncol"},{"key":"10.1016\/0959-8049(94)00286-E_BIB45","first-page":"342","article-title":"Randomized trials in cancer. A critical review by sites","volume":"Vol. 15","author":"Slevin","year":"1986"},{"key":"10.1016\/0959-8049(94)00286-E_BIB46","first-page":"53","article-title":"MACC (methotrexate, doxorubicin, cyclophosphamide and lomustine) versus cis-platinum and etoposide in the treatment of advanced nonsmall cell lung cancer","volume":"5","author":"Buccheri","year":"1986","journal-title":"Chemioterapia"},{"key":"10.1016\/0959-8049(94)00286-E_BIB47","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1002\/1097-0142(19820901)50:5<845::AID-CNCR2820500507>3.0.CO;2-S","article-title":"Benefits of polychemotherapy in advanced non-small-cell bronchogenic carcinoma","volume":"50","author":"Cormier","year":"1982","journal-title":"Cancer"},{"key":"10.1016\/0959-8049(94)00286-E_BIB48","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/0002-9343(69)90071-0","article-title":"Alkylating agents in bronchogenic carcinoma","volume":"46","author":"Green","year":"1969","journal-title":"Am J Med"},{"key":"10.1016\/0959-8049(94)00286-E_BIB49","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/bjc.1990.135","article-title":"A randomized trial of cisplatin and vindesine versus supportive care only in advanced nonsmall cell lung cancer","volume":"61","author":"Woods","year":"1990","journal-title":"Br J Cancer"},{"key":"10.1016\/0959-8049(94)00286-E_BIB50","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/1097-0142(19890401)63:7<1271::AID-CNCR2820630707>3.0.CO;2-6","article-title":"Supportive care versus supportive care and combination chemotherapy in metastatic non-small cell lung cancer. Does chemotherapy make a difference?","volume":"63","author":"Ganz","year":"1989","journal-title":"Cancer"},{"key":"10.1016\/0959-8049(94)00286-E_BIB51","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1002\/1097-0142(19910515)67:10<2443::AID-CNCR2820671008>3.0.CO;2-K","article-title":"Symptomatic treatment versus combination chemotherapy for patients with extensive non-small cell lung cancer","volume":"67","author":"Kaasa","year":"1991","journal-title":"Cancer"},{"key":"10.1016\/0959-8049(94)00286-E_BIB52","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1200\/JCO.1991.9.8.1453","article-title":"A randomized trial of alternating chemotherapy versus best supportive care in advanced non-small-cell lung cancer","volume":"9","author":"Cellerino","year":"1991","journal-title":"J Clin Oncol"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:095980499400286E?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:095980499400286E?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,15]],"date-time":"2024-12-15T22:25:47Z","timestamp":1734301547000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/095980499400286E"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1994,1]]},"references-count":52,"journal-issue":{"issue":"10","published-print":{"date-parts":[[1994,1]]}},"alternative-id":["095980499400286E"],"URL":"https:\/\/doi.org\/10.1016\/0959-8049(94)00286-e","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[1994,1]]}}}